NO20056004L - Nye galaktooligosakkaridsammensetning og fremstilling derav - Google Patents

Nye galaktooligosakkaridsammensetning og fremstilling derav

Info

Publication number
NO20056004L
NO20056004L NO20056004A NO20056004A NO20056004L NO 20056004 L NO20056004 L NO 20056004L NO 20056004 A NO20056004 A NO 20056004A NO 20056004 A NO20056004 A NO 20056004A NO 20056004 L NO20056004 L NO 20056004L
Authority
NO
Norway
Prior art keywords
novel
preparation
new
growth
mixture
Prior art date
Application number
NO20056004A
Other languages
English (en)
Other versions
NO335413B1 (no
Inventor
Glenn Gibson
Jacek Witold Slupinski
Georgios Tzortzis
Anthony Graham Wynne
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33568264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20056004(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0315266A external-priority patent/GB0315266D0/en
Priority claimed from GB0325224A external-priority patent/GB0325224D0/en
Priority claimed from GB0405837A external-priority patent/GB0405837D0/en
Application filed by Clasado Inc filed Critical Clasado Inc
Publication of NO20056004L publication Critical patent/NO20056004L/no
Publication of NO335413B1 publication Critical patent/NO335413B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Nye stammer av Bifidobacterium hifidum med evne til å produsere en ny galaktosidaseenzymaktivitet som omdanner laktose til en ny blanding av galaktooligosakkarider. Blandingen av oligosakkarider kan bli inkorporert i en mengde matvareprodukter eller dyrefór for å forbedre helsen i tarm ved å fremme vekst av bifidobakterier i tarmen og undertrykke veksten av patogene mikroflora.
NO20056004A 2003-06-30 2005-12-16 Bifidobacterium bifidum stamme og anvendelse derav, galaktooligosakkaridsammensetning, sammensetning og anvendelse derav, og fremgangsmåte for fremstilling av en substans for å fremme veksten av bifidobakterier NO335413B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0315266A GB0315266D0 (en) 2003-06-30 2003-06-30 Novel galactooligosaccharide composition and the preparation thereof
GB0325224A GB0325224D0 (en) 2003-10-29 2003-10-29 Novel galactooligosaccharide composition and the preparation thereof
GB0405837A GB0405837D0 (en) 2004-03-16 2004-03-16 Novel Galactooligosaccharide composition and the preparation thereof
PCT/GB2004/002815 WO2005003329A1 (en) 2003-06-30 2004-06-30 Novel galactooligosaccharide composition and the preparation thereof

Publications (2)

Publication Number Publication Date
NO20056004L true NO20056004L (no) 2006-01-03
NO335413B1 NO335413B1 (no) 2014-12-08

Family

ID=33568264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056004A NO335413B1 (no) 2003-06-30 2005-12-16 Bifidobacterium bifidum stamme og anvendelse derav, galaktooligosakkaridsammensetning, sammensetning og anvendelse derav, og fremgangsmåte for fremstilling av en substans for å fremme veksten av bifidobakterier

Country Status (22)

Country Link
US (1) US7883874B2 (no)
EP (1) EP1644482B2 (no)
JP (2) JP4384656B2 (no)
KR (1) KR100857500B1 (no)
AT (1) ATE360682T1 (no)
AU (1) AU2004254110B2 (no)
BR (1) BRPI0408911B1 (no)
CA (1) CA2520043C (no)
CY (1) CY1107671T1 (no)
DE (1) DE602004006133T3 (no)
DK (1) DK1644482T4 (no)
ES (1) ES2284028T5 (no)
GB (1) GB2412380B (no)
HK (1) HK1077323A1 (no)
IL (1) IL172553A (no)
MX (1) MXPA05010349A (no)
NO (1) NO335413B1 (no)
NZ (1) NZ542482A (no)
PL (1) PL1644482T5 (no)
PT (1) PT1644482E (no)
RU (1) RU2313572C2 (no)
WO (1) WO2005003329A1 (no)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2520043C (en) * 2003-06-30 2009-09-01 Clasado Inc. Novel galactooligosaccharide composition and the preparation thereof
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
GB0522740D0 (en) * 2005-11-08 2005-12-14 Clasado Inc Process for the production of oligosaccharides
GB0525857D0 (en) 2005-12-20 2006-02-01 Product and process
EP1803358A1 (en) 2005-12-28 2007-07-04 Laboratorios Ordesa, S.L Infant immunological formula
GB0601901D0 (en) * 2006-01-31 2006-03-08 Product and Process
AU2007213677B2 (en) † 2006-02-10 2012-04-05 Société des Produits Nestlé S.A. Oligosaccharide mixture
GB0606112D0 (en) * 2006-03-28 2006-05-03 Product and process
FR2900029B1 (fr) * 2006-04-25 2012-09-14 Bel Fromageries Procede d'aromatisation de produits fromagers.
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
EP2076271B1 (en) 2006-10-02 2011-09-14 Friesland Brands B.V. Inhibition of cholera toxins by galatooligosaccharides (gos)
EP1988096A1 (en) * 2007-04-26 2008-11-05 Laboratorios Ordesa, S.L Process for preparing a galactooligosaccharides powder
WO2009113030A2 (en) * 2008-03-12 2009-09-17 Tata Chemicals Ltd. Process for the production of galactooligosaccharides by free cells
GB0809921D0 (en) * 2008-05-30 2008-07-09 Clasado Inc Product and process therefor
US20090297660A1 (en) * 2008-06-02 2009-12-03 Kraft Food Holdings, Inc. Cheese Products Containing Galacto-Oligosaccharides And Having Reduced Lactose Levels
KR101121161B1 (ko) 2009-02-24 2012-03-19 주식회사 제노포커스 고당전이 활성의 신규한 베타-갈락토시다제 및 그 용도
SG10201901259RA (en) 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
CA2760999A1 (en) * 2009-03-13 2010-09-16 Mariana Barboza Prebiotic oligosaccharides
GB0906983D0 (en) * 2009-04-23 2009-06-03 Clasado Inc Novel use
BRPI0925002A2 (pt) * 2009-05-27 2016-06-21 Clasado Inc uso de uma composição para a prevenção de diarréia
TWI446914B (zh) * 2009-06-04 2014-08-01 Clasado Inc 製備預防旅人腹瀉發生藥物之組成物之用途
WO2010143940A1 (en) * 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
IT1395068B1 (it) * 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
US20110189342A1 (en) * 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
IL206678A0 (en) 2010-06-28 2010-12-30 Hcl Cleantech Ltd A method for the production of fermentable sugars
JP2017018135A (ja) * 2010-07-19 2017-01-26 アルラ フーズ アムバＡｒｌａ Ｆｏｏｄｓ Ａｍｂａ ガラクトオリゴ糖含有組成物およびそれを生産する方法
CA2805997A1 (en) * 2010-07-19 2012-01-26 Arla Foods Amba Galacto-oligosaccharide-containing composition and a method of producing it
EP2481299B1 (en) * 2011-01-31 2016-12-07 Dr. Fischer Gesundheitsprodukte GmbH Bifidobacterium bifidum strains for application in gastrointestinal diseases
GB2492559B (en) 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
MX350782B (es) 2011-07-22 2017-09-18 Abbott Lab Galacto-oligosacaridos para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
JP5980785B2 (ja) * 2011-09-08 2016-08-31 株式会社ヤクルト本社 新規ビフィズス菌及びその利用
US9617608B2 (en) 2011-10-10 2017-04-11 Virdia, Inc. Sugar compositions
PT2775852T (pt) * 2011-10-18 2016-11-08 Nestec Sa Composição para utilização no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
US20150087616A1 (en) * 2011-11-30 2015-03-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20130167837A1 (en) 2011-12-30 2013-07-04 Renmatix, Inc. Compositions comprising c5 and c6 monosaccharides
EP2814454A2 (en) 2012-02-14 2014-12-24 The Procter and Gamble Company Topical use of a skin-commensal prebiotic agent and compositions containing the same
GB201305708D0 (en) 2013-03-28 2013-05-15 Clasado Inc Novel use
WO2014189520A1 (en) 2013-05-24 2014-11-27 General Mills, Inc. Food products with yogurt whey
EP3030093B1 (en) * 2013-07-26 2017-09-06 Novozymes A/S POLYPEPTIDES HAVING alpha-L-GALACTOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
MX2016002638A (es) * 2013-08-30 2016-08-18 Abbott Lab Formulas de rehidratacion oral con prebioticos galactooligosacaridos.
GB201319531D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
US10695358B2 (en) 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
PL2896628T3 (pl) * 2014-01-20 2019-03-29 Jennewein Biotechnologie Gmbh Sposób wydajnego oczyszczania obojętnych oligosacharydów ludzkiego mleka (HMO) z fermentacji mikrobiologicznej
CA2954662C (en) 2014-07-09 2024-03-19 Midori Usa, Inc. Oligosaccharide compositions and methods for producing thereof
EP3222281B1 (en) * 2014-11-19 2020-01-08 Kabushiki Kaisha Yakult Honsha Preventive and therapeutic agent for celiac disease
EP3242871B1 (en) 2015-01-07 2019-11-06 Virdia, Inc. Methods for extracting and converting hemicellulose sugars
EP4209130A1 (en) 2015-01-26 2023-07-12 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
DK3354282T3 (da) 2015-01-26 2021-03-08 Kaleido Biosciences Inc Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
EP3285777B1 (en) 2015-04-23 2021-06-09 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
CA2985478A1 (en) 2015-05-27 2016-12-01 Virdia, Inc. Integrated methods for treating lignocellulosic material
US10190142B2 (en) 2016-01-25 2019-01-29 King-Prebiotics Biotechnology (Tw) Co., Ltd. High-purity galactooligosaccharide compositions, preparations, and applications thereof
CN109475151A (zh) * 2016-06-24 2019-03-15 叶塞纳吉控股有限公司 控制肠道微生物群中有害细菌的免疫调节和促生长组合物及其用途
EP3551194B1 (en) 2016-12-06 2023-10-18 DSM Nutritional Products, LLC Glycan polymers and related methods thereof
KR101955251B1 (ko) 2017-07-31 2019-03-08 최승오 독서대 겸용 얼굴베개
US20220233577A1 (en) 2017-11-03 2022-07-28 Kaleido Biosciences, Inc. Glycan preparations and methods of use for hyperammonemia
EP3862006A1 (en) 2017-11-03 2021-08-11 Kaleido Biosciences, Inc. Glycan preparations for the treatment of infection
KR20210089706A (ko) 2018-11-08 2021-07-16 칼레이도 바이오사이언시즈, 인크. 올리고사카라이드 조성물 및 그의 사용 방법
JPWO2020203782A1 (no) * 2019-03-29 2020-10-08
US20220218728A1 (en) * 2019-05-15 2022-07-14 N.V. Nutricia Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
EP4362708A1 (en) * 2021-07-01 2024-05-08 N.V. Nutricia Nutritonal compositions for gut barrier function
GB202200069D0 (en) * 2022-01-05 2022-02-16 Vemico Ltd Compositions and methods for immunomodulation via control of intestinal microbiome
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435389A (en) * 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JPS6259290A (ja) 1985-09-09 1987-03-14 Riyoushiyoku Kenkyukai イソラフイノ−ス及びその製造方法
JP2711095B2 (ja) * 1986-09-27 1998-02-10 ユニチカ株式会社 ビフイドバクテリウム菌の増殖促進剤の製造法
DK199887D0 (da) 1987-04-15 1987-04-15 Danisco Bioteknologi As Gaerstamme
JP2518663B2 (ja) * 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
US5149640A (en) * 1988-12-22 1992-09-22 Ajinomoto Co., Inc. Method for producing galactose transfer products
JP2819313B2 (ja) 1989-07-18 1998-10-30 焼津水産化学工業株式会社 Ｎ―アセチルラクトサミンの製造方法
JP2819312B2 (ja) 1989-07-18 1998-10-30 焼津水産化学工業株式会社 Ｎ―アセチルラクトサミンの製造法
CA2027835A1 (en) 1990-01-19 1991-07-20 William D. Prevatt Strains of phaffia rhodozyma containing high levels of astaxanthin
JP2750767B2 (ja) 1990-02-21 1998-05-13 雪印乳業株式会社 新規糖アルコール
JP2952439B2 (ja) † 1991-11-26 1999-09-27 株式会社ホーネンコーポレーション 新規飲食品素材
JPH05146296A (ja) 1991-11-27 1993-06-15 Yakult Honsha Co Ltd β−ガラクトシダーゼ遺伝子を含むＤＮＡ断片及び該ＤＮＡ断片を組み込んだプラスミド
JP2904687B2 (ja) 1993-09-17 1999-06-14 雪印乳業株式会社 新規オリゴ糖
FR2723963B1 (fr) 1994-08-31 1997-01-17 Gervais Danone Co Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
JP3246296B2 (ja) 1995-11-09 2002-01-15 宇部興産株式会社 半溶融金属の成形方法
JPH1023898A (ja) 1996-07-10 1998-01-27 Meiji Milk Prod Co Ltd Ｎ−アセチルラクトサミン誘導体の新規な製造法
KR100245383B1 (ko) 1996-09-13 2000-03-02 정훈보 교차홈 형성 전열관 및 그 제조 방법
JP2894293B2 (ja) 1996-09-17 1999-05-24 不二製油株式会社 ガラクタナーゼｓ−３９及びこれを産生するバチルスエスピーｓ−３９
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
JP3049693B1 (ja) 1998-12-10 2000-06-05 ソフィアインターナショナル株式会社 端末ターミナル
FR2789086B1 (fr) 1999-02-03 2003-01-31 Alain Rambach Procede de detection de bacteries cultivees en condition anaerobie
AU2001262068B2 (en) * 2000-05-26 2006-07-06 Arla Foods Amba A new enzyme isolated from a bifidobacterium
EP1227152A1 (en) 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0303716D0 (en) 2003-02-18 2003-03-19 Mars Uk Ltd Food product and process
CA2520043C (en) * 2003-06-30 2009-09-01 Clasado Inc. Novel galactooligosaccharide composition and the preparation thereof

Also Published As

Publication number Publication date
NZ542482A (en) 2008-05-30
PL1644482T5 (pl) 2015-05-29
WO2005003329A1 (en) 2005-01-13
DK1644482T3 (da) 2007-08-13
JP2007527199A (ja) 2007-09-27
DK1644482T4 (da) 2014-12-15
DE602004006133T2 (de) 2007-11-22
US20070274955A1 (en) 2007-11-29
PL1644482T3 (pl) 2007-09-28
US7883874B2 (en) 2011-02-08
KR20050111624A (ko) 2005-11-25
JP4384656B2 (ja) 2009-12-16
IL172553A (en) 2010-06-30
EP1644482B2 (en) 2014-10-01
PT1644482E (pt) 2007-06-25
MXPA05010349A (es) 2006-03-08
RU2005129997A (ru) 2006-06-10
GB0513376D0 (en) 2005-08-03
HK1077323A1 (en) 2006-02-10
IL172553A0 (en) 2006-04-10
AU2004254110A1 (en) 2005-01-13
DE602004006133T3 (de) 2014-12-24
JP2009189374A (ja) 2009-08-27
CA2520043C (en) 2009-09-01
GB2412380B (en) 2005-11-09
ES2284028T5 (es) 2014-12-04
RU2313572C2 (ru) 2007-12-27
CY1107671T1 (el) 2013-04-18
JP4932874B2 (ja) 2012-05-16
ES2284028T3 (es) 2007-11-01
CA2520043A1 (en) 2005-01-13
NO335413B1 (no) 2014-12-08
ATE360682T1 (de) 2007-05-15
DE602004006133D1 (de) 2007-06-06
EP1644482B1 (en) 2007-04-25
EP1644482B8 (en) 2007-10-03
BRPI0408911B1 (pt) 2016-07-26
BRPI0408911A (pt) 2006-03-28
GB2412380A (en) 2005-09-28
KR100857500B1 (ko) 2008-09-08
EP1644482A1 (en) 2006-04-12
AU2004254110B2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
NO20056004L (no) Nye galaktooligosakkaridsammensetning og fremstilling derav
ATE463558T1 (de) Beta-galactosidase mit transgalactosylierungsaktivität
HK1121779A1 (en) Galactosidase with alph-galactosyltransferase activity
MY144029A (en) Alpha-galactosidase from bifidobacterium bifidum and its use
DK1332223T3 (da) Fremgangsmåde til screening for probiotiske stammer af slægten Bifidobacterium
GEU20061256Y (en) Yoghurt

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees